• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA杂交技术及其在传染病诊断中的应用。

DNA hybridization techniques and their application to the diagnosis of infectious diseases.

作者信息

Tenover F C

机构信息

Nosocomial Pathogens Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.

出版信息

Infect Dis Clin North Am. 1993 Jun;7(2):171-81.

PMID:8345164
Abstract

Several commercial DNA probe assays are widely used in clinical microbiology laboratories. These include culture-confirmation assays for Mycobacterium species, which are recommended by CDC because they are both rapid and accurate, and culture-confirmation assays for N. gonorrhoeae. Probe assays for direct detection of N. gonorrhoeae and C. trachomatis are also widely used in public health and large reference laboratories. In many cases, the probe assays have decreased the time to identification of positive cultures and improved detection of these pathogens because they do not depend on the presence of viable organisms to achieve a positive result. Nucleic acid amplification assays hold promise for the rapid detection and identification of many infectious agents. PCR using universal primers enables researchers to identify new agents of disease that cannot be cultured in vitro; more importantly, PCR provides a method for detecting the presence of any bacterial species, including common organisms, in normally sterile body fluids, such as blood and cerebrospinal fluids. The use of such primers may well give PCR the broad-based approach needed to identify organisms in the clinical microbiology laboratory of the future.

摘要

几种商业DNA探针检测方法在临床微生物学实验室中被广泛使用。这些方法包括用于分枝杆菌属的培养确认检测,美国疾病控制与预防中心(CDC)推荐使用这些方法,因为它们既快速又准确;还有用于淋病奈瑟菌的培养确认检测。用于直接检测淋病奈瑟菌和沙眼衣原体的探针检测方法也在公共卫生和大型参考实验室中广泛使用。在许多情况下,探针检测方法缩短了阳性培养物的鉴定时间,并提高了对这些病原体的检测能力,因为它们不依赖活生物体的存在来获得阳性结果。核酸扩增检测方法有望快速检测和鉴定许多感染因子。使用通用引物的聚合酶链反应(PCR)使研究人员能够鉴定出无法在体外培养的新病原体;更重要的是,PCR提供了一种检测正常无菌体液(如血液和脑脊液)中任何细菌种类(包括常见生物体)存在的方法。使用这样的引物很可能会使PCR成为未来临床微生物学实验室鉴定生物体所需的基础广泛的方法。

相似文献

1
DNA hybridization techniques and their application to the diagnosis of infectious diseases.DNA杂交技术及其在传染病诊断中的应用。
Infect Dis Clin North Am. 1993 Jun;7(2):171-81.
2
Rapid, species-specific detection of uropathogen 16S rDNA and rRNA at ambient temperature by dot-blot hybridization and an electrochemical sensor array.通过斑点杂交和电化学传感器阵列在常温下对尿路病原体16S rDNA和rRNA进行快速、物种特异性检测。
Mol Genet Metab. 2005 Jan;84(1):90-9. doi: 10.1016/j.ymgme.2004.11.006. Epub 2004 Dec 13.
3
Molecular diagnostic testing for infectious diseases using TMA technology.使用转录介导扩增(TMA)技术进行传染病的分子诊断检测。
Expert Rev Mol Diagn. 2001 Nov;1(4):445-55. doi: 10.1586/14737159.1.4.445.
4
[Mycobacterial tests].[分枝杆菌检测]
Kekkaku. 2008 Jan;83(1):43-59.
5
Bacterial species identification after DNA amplification with a universal primer pair.使用通用引物对进行DNA扩增后的细菌物种鉴定。
Mol Genet Metab. 1999 Mar;66(3):205-11. doi: 10.1006/mgme.1998.2795.
6
Infectious agents.传染原
IARC Sci Publ. 2011(163):175-87.
7
Nucleic acid probes in infectious diseases.传染病中的核酸探针
Curr Clin Top Infect Dis. 1989;10:174-93.
8
Real-time assays with molecular beacons and other fluorescent nucleic acid hybridization probes.使用分子信标和其他荧光核酸杂交探针的实时检测法。
Clin Chim Acta. 2006 Jan;363(1-2):48-60. doi: 10.1016/j.cccn.2005.04.037. Epub 2005 Aug 18.
9
Probe technology for the clinical microbiology laboratory.临床微生物学实验室的探针技术
Arch Pathol Lab Med. 1993 Jun;117(6):578-83.
10
Modern diagnosis (with molecular tests) of acute infectious diarrhea.
Gastroenterol Clin North Am. 1993 Sep;22(3):661-82.

引用本文的文献

1
Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria.临床微生物学实验室实用指南:分枝杆菌。
Clin Microbiol Rev. 2018 Jan 31;31(2). doi: 10.1128/CMR.00038-17. Print 2018 Apr.